Advances in the Physicochemical Profiling of Opioid Compounds of Therapeutic Interest
Open accessThe DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
Abstract
This review focuses on recent developments in the physicochemical profiling of morphine and other opioids. The acid‐base properties and lipophilicity of these compounds is discussed at the microscopic, species‐specific level. Examples are provided where this type of information can reveal the mechanism of pharmacokinetic processes at the submolecular level. The role of lipophilicity in quantitative structure–activity relationship (QSAR) studies of opioids is reviewed. The physicochemical properties and pharmacology of the main metabolites of morphine are also discussed. Recent studies indicate that the active metabolite morphine‐6‐glucuronide (M6G) can contribute to the analgesic activity of systemically administered morphine. The unexpectedly high lipophilicity of M6G partly accounts for its analgesic activity. When administered parenterally, another suspected minor metabolite, morphine‐6‐sulfate (M6S) has superior antinociceptive effects to those of morphine. However, because sulfate esters of morphine derivatives cannot cross the blood‐brain barrier these esters may be good candidates to develop peripheral analgesic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry
Beale, J. M., & Block, J. H. (2011) · Andalas University Repository (Andalas University) · Cited by 914
Abraham, M. H., Chadha, H. S., Whiting, G. S., & Mitchell, R. C. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830806 · Cited by 766
van de Waterbeemd, H., Camenisch, G., Folkers, G., Chretien, J. R., & Raevsky, O. A. (1998) · Journal of Drug Targeting · doi:10.3109/10611869808997889 · Cited by 587
Clinical Pharmacology of Opioids for Pain
Inturrisi, C. E. (2002) · The Clinical Journal of Pain · doi:10.1097/00002508-200207001-00002 · Cited by 571
CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure
Rankovic, Z. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501535r · Cited by 548
Wager, T. T., Chandrasekaran, R. Y., Hou, X., Troutman, M. D., Verhoest, P. R., Villalobos, A., & Will, Y. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100007x · Cited by 477
Absorption and Drug Development: Solubility, Permeability, and Charge State
Avdeef, A. (2012) · Wiley eBooks · doi:10.1002/9781118286067 · Cited by 446
Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.
Paul, D., Standifer, K. M., Inturrisi, C. E., & Pasternak, G. W. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20832-1 · Cited by 393
Lipid solubility and drug penetration of the blood brain barrier
Oldendorf, W. H. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-147-38444 · Cited by 373
The significance of acid/base properties in drug discovery
Manallack, D. T., Prankerd, R. J., Yuriev, E., Oprea, T. I., & Chalmers, D. K. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35348b · Cited by 329
Research works printed but not linked: 5
- 14. T. L. Yaksh, M. S. Wallace, Goodman & Gilman's The Pharmaceutical Basis of Therapeutics (Eds.: L. L. Brunton, B. A. Chabner, B. C. Knollmann), McGraw-Hill Medical 2010, pp. 481-527.
- 23. A. E. Jacobson, W. A. Klee, W. J. Dunn, Eur. J. Med. Chem. 1977, 12, 49- 52.
- 24. A. E. Jacobson, NIDA Res. Monogr. 1978, 22, 129-45.
- 48. D. Wu, Y. S. Kang, U. Bickel, W. M. Pardridge, Drug Metab. Dispos. 1997, 25, 768-771.
- 60. J. Lötsch, G. Geisslinger, Clin. Pharmacokinet. 2001, 40, 485-499.
Cited by
Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic
Balyan, R., Hahn, D., Huang, H. D., & Chidambaran, V. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1721458 · Cited by 31
“[30] and will not be presented further here).”
BackgroundOpioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Shaabani, N., Chan, N. W. C., Lee, W. E., & Jemere, A. B. (2020) · Journal of The Electrochemical Society · doi:10.1149/1945-7111/abbb0d · Cited by 27
Physicochemical Properties of Zwitterionic Drugs in Therapy
Mazák, K., & Noszál, B. (2020) · ChemMedChem · doi:10.1002/cmdc.202000164 · Cited by 23
Self-citationA Molecularly Imprinted Sol-Gel Electrochemical Sensor for Naloxone Determination
Shaabani, N., Chan, N. W. C., & Jemere, A. B. (2021) · Nanomaterials · doi:10.3390/nano11030631 · Cited by 23
“55 and it exists in four tautomeric forms in solution [51].”
Background
Metadata
- Authors
- Mazák, K., Noszál, B., & Hosztafi, S.
- Affiliations
- Semmelweis University (HU)
- Corresponding author
- Mazák, Károly
- Venue
- ChemistryOpen
- Publisher
- Wiley
- Published
- 2019-07
- Volume
- 8
- Issue
- 7
- Pages
- 879-887
- ISSN
- 2191-1363 (ISSN-L)
- PMC
- PMC6610444
- OpenAlex
- W2955693718
- Semantic Scholar
- 922c3a0bc3e9d60e0d7c75fff264b3098df2f0dd
- Cited by
- 27
- References
- 65
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 1
- FWCI
- 0.83
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ChemistryOpen (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fonds National de la Recherche Luxembourg
- Hungarian Scientific Research Fund (T 73804)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- morphine, opioids, physicochemical profiling, lipophilicity, acid-base properties, pharmacokinetics, QSAR, morphine metabolites, morphine-6-glucuronide, analgesic activity, blood-brain barrier, peripheral analgesics, antinociception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advances in the Physicochemical Profiling of Opioid Compounds of Therapeutic Interest. https://app.cochat.ai/papers/10.1002/open.201900115
- The paper
- Mazák, K., Noszál, B., & Hosztafi, S. (2019). Advances in the Physicochemical Profiling of Opioid Compounds of Therapeutic Interest. ChemistryOpen. https://doi.org/10.1002/open.201900115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.